Company page
Cytek Biosciences, Inc.
Cytek Biosciences, Inc. (ticker: CTKB) is a public company operating in the American market, with a market capitalization of approximately $486.87 million. The company specializes in advanced cell analysis technologies, providing innovative solutions for researchers and clinicians. Cytek aims to enhance the understanding of cellular biology through its cutting-edge products and services.

- Ticker
- CTKB:NASDAQ
- Asset type
- Stock
- Market cap
- $486.9M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD